GlassScriptPhysician profile
Andrew T Doris
NPI 1760536312
$2,900.40
in general payments reported to CMS, 2019-2025
26 companies · $597 in 2025
The $597 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $133 · 2021: $351 · 2022: $406 · 2023: $657 · 2024: $482 · 2025: $597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,311 · Travel and Lodging: $353 · Education: $71.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,310.99 |
| Travel and Lodging | $352.60 |
| Education | $71.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $489.36 | 2019-2023 | Solyx Sis System |
| Astellas Pharma US INC | $442.17 | 2019-2025 | Veozah, Myrbetriq |
| Amgen INC. | $273.38 | 2019-2025 | Evenity |
| Abbvie INC. | $229.93 | 2019-2024 | |
| Coopersurgical, INC. | $209.29 | 2019-2025 | Paragard T 380a, Endosee |
| Organon LLC | $177.67 | 2023-2025 | Jada System, Nexplanon |
| Optumhealth Care Solutions, LLC | $166.73 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Bayer Healthcare Pharmaceuticals INC. | $139.56 | 2019-2025 | |
| Baxter Healthcare | $113.46 | 2020-2021 | |
| Myovant Sciences INC. | $104.29 | 2021 | |
| Millicent US INC | $90.17 | 2020-2025 | |
| Davol INC. | $67.37 | 2021-2024 | Arista Ah Flexitip |
| Hologic Sales and Service, LLC | $66.80 | 2022-2025 | Novasure, Aptima, Myosure Tissue Removal Device |
| Daiichi Sankyo INC. | $51.55 | 2019-2020 | |
| Therapeuticsmd, INC. | $51.44 | 2019-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $50.25 | 2019-2023 | Slynd |
| Mayne Pharma Commercial LLC | $27.85 | 2023-2025 | |
| Aspira Women'S Health INC | $23.66 | 2024 | Ova1 |
| Biogen, INC. | $23.41 | 2025 | Zurzuvae |
| Pfizer INC. | $22.20 | 2025 | |
| Avion Pharmaceuticals | $14.86 | 2019 | |
| Solventum Corporation | $14.82 | 2025 | Prevena |
| Currax Pharmaceuticals LLC | $14.49 | 2021 | |
| Merck Sharp & Dohme LLC | $13.05 | 2019 | |
| Amag Pharmaceuticals, INC. | $11.43 | 2019 | |
| Lupin INC. | $11.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Doris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.